Momenta, the leading Industrial Impact® venture capital firm, has increased its investment in DataHow as part of the company's bridge financing round. Existing investors also participated in the financing, supporting the company's expansion into real-time connectivity, model-driven process control, and downstream processing capabilities.
Biomanufacturing has become increasingly data rich, giving manufacturers unprecedented insight into how complex biological processes behave. Yet many of the industry's most important decisions still depend on experimentation, manual analysis, and operator judgment. As development and manufacturing environments become more connected, the opportunity is shifting from understanding processes to actively guiding and controlling them. In that sense, bioprocessing is moving from process insight to process control.
Over the past decade, biomanufacturers have invested heavily in digitization, automation, and data infrastructure. As a result, the industry now has more process information than ever before. The challenge is no longer collecting data. It is translating that information into better operational decisions.
DataHow's evolution reflects that transition.
Our continued investment reflects the same conviction that led us to back DataHow at Series A. The company's progress toward real-time, model-driven process control is exactly the kind of shift from automation to autonomy that we believe will define the next era of industrial manufacturing.
DataHow represents this transition in practice. The company began by helping process engineers better understand and optimize complex bioprocesses. Increasingly, its focus is shifting toward bringing those insights directly into manufacturing environments through real-time connectivity, process guidance, and model-driven control capabilities.
As process models become connected to laboratory and manufacturing systems, they increasingly move from analytical tools to operational tools. The long-term opportunity is not simply improving process understanding. It is enabling better decisions closer to the point of execution.
The significance extends beyond a single platform.
The implications extend well beyond bioprocess development. As biomanufacturing becomes increasingly digital, competitive advantage will come from how effectively process knowledge is translated into operational outcomes.
The industry's next leaders will not differentiate themselves through access to more data, but through their ability to convert knowledge into faster decisions, more consistent processes, and ultimately greater operational control. That is why we believe model-driven bioprocessing will become a foundational capability for the next generation of biomanufacturing.
Our customers continue to push us toward real-time environments and expanded manufacturing applications.
This investment allows us to accelerate that roadmap and bring our technologies closer to where critical manufacturing decisions are made.
Over the next decade, value creation in biomanufacturing will increasingly come from the ability to convert process knowledge into operational advantage.
The future of biomanufacturing will not be defined by who generates the most process data. It will be defined by who can transform process knowledge into process control.
That transition is already underway.
DataHow is helping build the foundation for that future.
Momenta is the leading Industrial Impact® venture capital firm, accelerating industrial innovators across energy, manufacturing, smart spaces, and the supply chain. Our team of deep industry operators has helped scale industry leaders and innovators to improve critical industries, the environment, and people's quality of life for over a decade. PitchBook recognized Momenta as a Top VC Fund Manager from 2023 through 2026 in its Global Manager Performance Score League Tables. For more information, please visit http://www.momenta.vc
Schedule a call to learn more about our Industrial Impact investments.